Having a healthy diet, regular exercise, adequate sleep, hydration, and proper stress management would go a long way to ...

AIC-100 is under clinical development by AffyImmune Therapeutics and currently in Phase I for Anaplastic Thyroid Cancer.

Poly-ICLC is under clinical development by Oncovir and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs for Melanoma have a 27% phase transition success rate (PTSR) ...

Severe COVID-19 patients exhibit excessive cytokine levels linked to immune system dysregulation ... into the cytosol. This ...

Tumor Microenvironment: Investigating the role of the tumor microenvironment and its components, including immune cells, ...

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.

Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.

Medically reviewed by Ashley Baumohl, RD L-glutamine, also known as glutamine, is an amino acid. Amino acids are organic ...

Flu season leads to an increase in respiratory illnesses, and a healthy immune system is essential to combat them. Consuming ...

The immune system is our unsung hero when it comes to staying healthy and sickness-free. Without us noticing, it mounts round ...

The director of solid tumor therapy at Stanford Medicine describes how cellular therapies are transforming cancer care.